Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-25 @ 8:54 PM
Study NCT ID:
NCT00325156
Status:
COMPLETED
Last Update Posted:
2020-01-02
First Post:
2006-02-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2007-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-08-23
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-08
First Submit QC Date:
None
Study First Post Date:
2006-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-14
Results First Submit QC Date:
None
Results First Post Date:
2017-02-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-26
Last Update Post Date:
2020-01-02
Last Update Post Date Type:
ACTUAL